BASF and IFF announce strategic collaboration to drive next-generation enzyme and polymer innovation
Advertisement
BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, announced a strategic collaboration with International Flavors & Fragrances Inc. (IFF), a global leader in bioscience innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications.
This collaboration brings together two industry leaders with a shared vision: to develop high-performance, sustainable solutions that meet evolving consumer and market demands. By combining advanced chemical capabilities and expertise in biotechnology and protein engineering from BASF and IFF, the partnership aims to deliver breakthrough solutions at scale that enhance cleaning performance, improve personal care formulations, reduce environmental impact, and support the transition to a more sustainable future.
“This partnership marks a strategically significant step for both companies,” said Michael Heinz, member of the Board of Executive Directors of BASF. “By combining our research and development expertise, we are creating the foundation to bring large-scale innovative solutions to market faster for our customers.”
“We are very excited about the collaboration with BASF to jointly unlock new potential in enzyme and polymer technologies,” said Erik Fyrwald, CEO of IFF. “Our partnership enables us to develop market-driven solutions that create sustainable value for both the industry and the environment.”
The joint effort will focus on innovative enzyme systems and biobased polymers, enabling customers to achieve superior performance while reducing resource consumption. Both companies will maintain independent operations and competitive positioning, while leveraging complementary strengths to accelerate innovation and expand choices for customers worldwide.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Smartbax secures 4.7 million euros in Pre-Series A funding for the further development of a novel antibiotic up to preclinical stage - Lead candidate against a novel target in Gram-negative bacteria has already been validated in infection models
FIRST LABS - Laboratory start-up support for start-ups - The Rock Capital Group is expanding its concept of ready-to-use laboratories in the life science hub at SKYGATE in Hallbergmoos, especially for start-ups and smaller companies
From beer to useful fats and medicines - The spent grain from beer brewing can be used to make microcapsules that can preserve omega-3 oils and medicines
AI models for drug design fail in physics
Targeted protein degradation: Researchers find new way to combat harmful proteins in tumour cells - Domino effect in the fight against cancer
Chemistry meets biology: controlling artificial cell membranes through catalysis - Researchers develop an artificial metalloenzyme-based platform that enables programmable control of artificial membrane behavior
QIAGEN to acquire Parse Biosciences - Entering the age of single-cell AI
Setting the Course for AI-Assisted Radiology - Fraunhofer MEVIS and Radboud University Medical Center have founded the spin-off Plain Medical
Ancient viral DNA shapes modern human placentas - “It’s a reminder that there is much more to learn about our genome and how ancient infections can influence who we are today”
Analytica 2026: AI as a driver of digital transformation - Laboratory of the future in action
How the principle of cheese noodles helps against Alzheimer's
